DID YOU KNOW? DTIC has over 3.5 million final reports on DoD funded research, development, test, and evaluation activities available to our registered users. Click
HERE to register or log in.
Accession Number:
AD1064689
Title:
Cannabidivarin (CBDV) Versus Placebo in Children with Autism Spectrum Disorder (ASD)
Report Date:
2018-08-01
Abstract:
The CDC currently estimates 1 in 59 children have Autism Spectrum Disorder (ASD). Children with ASD have problems with social communication, irritability, repetitive behaviors, impulsivity, temper tantrums, and a high caregiver burden. The only medications approved by the FDA for symptoms of ASD are aripiprazole and risperidone. Both of these are used to reduce irritability but have short-term and long-term side effects.
Document Type:
Conference:
Journal:
Pages:
42
File Size:
0.69MB
W81XWH-17-1-0253
(W81XWH1710253);
Contracts:
Grants:
Distribution Statement:
Approved For Public Release
